Качественное офтальмологическое оборудование для профессионалов!
Тел.: +7 495 662 7866

Ellex

Dr. Chirag Shah from Ophthalmic Consultants of Boston will be at AAO 2017 to discuss the clinical trial results in more detail. See below for session details:

Saturday, 11 November
Ellex Exhibit #4040
10.00 – 11.00am

Saturday, 11 November
Ellex Exhibit #4040
4.00 – 5.00pm

*These sessions are not affiliated with the official program of AAO 2017

Fifty-two (52) patients were enrolled in the trial and were randomly assigned to laser vitreolysis or sham YAG (control). In the YAG group, 53% of patients reported significantly or completely improved symptoms, versus 0% of the sham group. Masked photography grading revealed 95% of the YAG group had significantly (50-70% better) or completely (100% better) improved floaters compared with 0% of the sham group. There were no significant adverse events.